Alnylam Pharmaceuticals Inc (LTS:0HD2)
$ 215.17 -4.99 (-2.27%) Market Cap: 29.33 Bil Enterprise Value: 27.29 Bil PE Ratio: 40.74 PB Ratio: 21.65 GF Score: 69/100
Sorry the transcript is not found. Please try another one.